A Phase 1 Study of of Anti-CD7 Allogeneic CAR-T Cell Therapy (WU-CART-007) in Patients With Relapsed or Refractory T-ALL/LBL
Clinical trial NCT04984356 · COMPLETED
Trial details
- NCT number
- NCT04984356
- Sponsor
- Allotera Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-14
- Primary completion
- 2024-08-08
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.